Compound Detail

CHEMBL3347616

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

OC[C@H]1O[C@@H](n2cc(C(c3ccc(Br)cc3)c3cn([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c4ccc(Br)cc34)c3cc(Br)ccc32)[C@H](O)[C@@H](O)[C@@H]1O

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL3347616
Phase	Preclinical
Structure Type	MOL
InChI Key	BKCZSOINXZTKIO-YHSHYRDHSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

883.4

MW (Da)

3.01

ALogP

HBA

HBD

190.2

PSA (Å²)

0.12

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 3 meas. best 5.6

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
A549 CHEMBL392	IC50	5.6	5.6	2500.0	1
HeLa CHEMBL399	IC50	4.57	4.57	27000.0	1
MCF7 CHEMBL387	IC50	4.29	4.29	51100.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
A549	IC50	=	2500.0	nM	5.6	Cytotoxicity against human A549 cells assessed as growth inhibition after 48 hrs...	-
HeLa	IC50	=	27000.0	nM	4.57	Cytotoxicity against human HeLa cells assessed as growth inhibition after 48 hrs...	-
MCF7	IC50	=	51100.0	nM	4.29	Cytotoxicity against human MCF7 cells assessed as growth inhibition after 48 hrs...	-

PubMed	DOI	Target Context	# Activities
-	10.1039/C2MD20098H	MCF7	1
-	10.1039/C2MD20098H	HeLa	1
-	10.1039/C2MD20098H	A549	1

Data from ChEMBL 36 via Core Engine